AKT1 and gastric cancer: In our study, SQWCF was confirmed to hinder both PI3K-AKT and MAPK signaling pathways and boost downstream apoptotic signaling, suggesting that SQWCF may play an anti-GC role as an inhibitor of PI3K-AKT and MAPK signaling pathways.